Loading...
Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine
Human papillomavirus is considered the causative factor for cervical cancer, which accounts for approximately 5% of the global cancer burden and more than 600,000 new cases annually that are attributable to HPV infection worldwide. The first-generation prophylactic HPV vaccines, Gardasil® and Cervar...
Na minha lista:
| Udgivet i: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5647960/ https://ncbi.nlm.nih.gov/pubmed/28699820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1346755 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|